UPDATED Jul 25, 2024
Explore the Taiwanese (TAIEX) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
6566 | NT$5.20 | 3.6% | -65.3% | NT$176.5m | n/a | PB1.3x | n/a | n/a | ||
3705 | NT$54.60 | 0% | 24.1% | NT$14.5b | n/a | PE15.8x | n/a | 4.2% | ||
6848 | NT$18.50 | 0% | 9.5% | NT$240.0m | n/a | PE37.3x | n/a | 2.4% | ||
4105 | NT$75.10 | 0% | -2.7% | NT$18.7b | NT$78.00 | PE16x | n/a | 4.7% | ||
6935 | NT$28.00 | 0% | -28.7% | NT$1.0b | n/a | PE66.2x | n/a | 0.5% | ||
6461 | NT$29.00 | 0% | -4.8% | NT$4.0b | n/a | PS107.8x | n/a | n/a | ||
6864 | NT$30.25 | 0% | 9.8% | NT$756.3m | n/a | n/a | n/a | n/a | ||
4117 | NT$21.20 | 0% | -9.6% | NT$1.3b | n/a | PS4.8x | n/a | n/a | ||
8432 | NT$61.40 | 0% | 30.2% | NT$2.4b | n/a | PE25.6x | n/a | 2.1% | ||
7754 | NT$42.80 | 0% | n/a | NT$4.0b | n/a | PS27.9x | n/a | n/a | ||
4119 | NT$91.50 | 0% | -12.9% | NT$10.9b | n/a | PE39.6x | n/a | 1.4% | ||
6535 | NT$205.00 | 0% | 214.9% | NT$33.8b | NT$244.00 | PS633.3x | E111.0% | n/a | ||
6932 | NT$15.80 | 0% | -28.3% | NT$6.6b | n/a | PS6362.2x | n/a | n/a | ||
6817 | NT$101.00 | 0% | 16.1% | NT$1.9b | n/a | PE11.7x | n/a | 6.5% | ||
6483 | NT$18.65 | 0% | n/a | NT$1.2b | n/a | PS28430.4x | n/a | n/a | ||
6539 | NT$72.50 | 0% | -61.6% | NT$505.6m | n/a | PE3.3x | n/a | 20.0% | ||
4133 | NT$32.80 | 0% | -3.1% | NT$2.0b | n/a | PE33.3x | n/a | 2.2% | ||
6794 | NT$80.00 | 0% | -7.2% | NT$4.7b | n/a | PS199.5x | n/a | n/a | ||
4192 | NT$45.20 | 0% | -7.5% | NT$1.6b | n/a | PS76.2x | n/a | n/a | ||
6562 | NT$14.25 | 0% | -62.3% | NT$1.7b | n/a | PE2097.4x | n/a | 0% | ||
6808 | NT$39.30 | 0% | 45.0% | NT$2.6b | n/a | PS127.3x | n/a | n/a | ||
7729 | NT$27.75 | 0% | n/a | NT$1.5b | n/a | n/a | n/a | n/a | ||
3176 | NT$42.35 | 0% | 30.5% | NT$5.9b | n/a | PS4.7x | n/a | n/a | ||
1752 | NT$47.60 | 0% | -21.8% | NT$4.8b | n/a | PE30.2x | n/a | 4.2% |